Prolonged Survival of Patients Receiving Trastuzumab Beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)
Oncology Research and Treatment - Switzerland
doi 10.1159/000088296
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2005
Authors
Publisher
S. Karger AG